Latest Nicholas J. Vogelzang Stories
Today, the Mesothelioma Applied Research Foundation (Meso Foundation) released a statement from the chair of its board of directors in which it discusses imminent improvements to the current standard
Honorees will be announced Friday, May 29, during celebration in Chicago. PLAINSBORO, N.J.
- Note: This release corresponds to ASCO abstracts LBA8512, 8587, 8590, TPS8609, TPS8608, LBA7005, 7012, TPS8599, TPS8601, 7024, TPS7095, TPS7096, 5005, 5047, 5053, 5014, 5028, TPS5071, TPS5084, 10503,
HORSHAM, Pa., March 30, 2015 /PRNewswire/ -- The U.S.
The Oncology Institute of Hope and Innovation announces the opening of the following clinical trial that may benefit some prostate cancer patients. Downey, CA
Data from Multiple Studies Include Potential Ability for Technology to Further Subtype Patients, Guide Treatment Decisions SAN DIEGO, Feb.
Multiple Studies of Decipher Prostate Cancer Classifier Presented at 2015 ASCO Genitourinary Symposium SAN DIEGO, Feb.
Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct.
Final data after 49-month follow-up analysis in chemotherapy-naïve men with metastatic castration-resistant prostate cancer presented at European Society for Medical Oncology (ESMO) 2014 Congress
Final analysis of Phase 3 COU-AA-302 study presented at the European Society for Medical Oncology (ESMO) 2014 Congress HORSHAM, Pa., Sept.
- A woman chauffeur.
- A woman who operates an automobile.